GlassScriptPhysician profile
Elisheva Gomez
NPI 1871851659
$2,926.98
in general payments reported to CMS, 2019-2025
11 companies · $17.55 in 2025
The $17.55 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,279 · 2022: $855 · 2023: $628 · 2024: $148 · 2025: $17.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,270.84 | 2021-2024 | |
| Novo Nordisk INC | $610.05 | 2021-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $442.43 | 2021-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $252.28 | 2021-2023 | Breztri, Farxiga |
| Amarin Pharma, INC. | $83.91 | 2021-2023 | |
| Nevro Corp. | $63.95 | 2021 | |
| Amgen INC. | $56.41 | 2022-2024 | Evenity, Prolia |
| Ironwood Pharmaceuticals, INC | $51.21 | 2021 | |
| Glaxosmithkline, LLC. | $44.92 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $37.46 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisheva Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.